Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension
- 1 January 2006
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 130 (1), 120-126
- https://doi.org/10.1053/j.gastro.2005.10.013
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pulmonary-Hepatic vascular Disorders (PHD)European Respiratory Journal, 2004
- Clinical classification of pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertensionJournal of the American College of Cardiology, 2004
- Diagnosis and differential assessment of pulmonary arterial hypertensionJournal of the American College of Cardiology, 2004
- Haemodynamic evaluation of pulmonary hypertension.European Respiratory Journal, 2002
- ATS StatementAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Pulmonary Artery Pressure–Flow Relations after Prostacyclin in Primary Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2002
- 7 Haemodynamic assessmentBailliere's Clinical Gastroenterology, 1995
- Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.American Journal of Respiratory and Critical Care Medicine, 1995
- Beta-Adrenergic–Antagonist Drugs in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal VaricesNew England Journal of Medicine, 1991